A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

NCT02815488 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

118

Enrollment

INDUSTRY

Sponsor class

Stopped Very poor recruitment in the Part 4 of the study

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: CHF6297 (Part 1 - SAD)
DRUG: Placebo (Part 1 - SAD)
DRUG: CHF6297 (Part 2 - MAD)
DRUG: Placebo (Part 2 - MAD)
DRUG: CHF6297 (Part 3)
DRUG: Placebo (Part 3)
DRUG: CHF6297 (Part 4)
DRUG: Placebo (Part 4)

Sponsor

Chiesi Farmaceutici S.p.A.